Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of fenebrutinib, and bone marrow transplantation as an effective long-term treatment.
Women with multiple sclerosis, particularly after menopause, experience a higher risk of relapse-independent worsening, ...
With over 1 million Americans affected by multiple sclerosis (MS), we wanted to learn more about its symptoms, particularly ...
This study demonstrated progressive CP enlargement over time in individuals with RRMS, averaging 1.4% a year with significant variation per participant. CP enlargement correlated with the expansion of ...
TG Therapeutics, Inc. announced new data presentations for BRIUMVI® (ublituximab-xiiy) at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) annual meeting, highlighting its efficacy for ...
Good physical performance is associated with better cognition in people with relapsing-remitting MS, according to a recent study by the University of Eastern Finland. Good functional capacity was also ...
Please provide your email address to receive an email when new articles are posted on . Top-line results of a phase 2 clinical trial for an adipose-derived autologous mesenchymal stem cell therapy to ...
Dear Doctors: My older brother is 33 years old and was recently diagnosed with multiple sclerosis. I don't want to bother him with a lot of questions, but I would like to learn more about it. Can you ...
Briumvi is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS.
So declared Selma Blair on stage at Flow Space Women's Health Summit in Los Angeles on Oct. 9, where the actress spoke about ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Multiple ...
Riley Shepard isn’t just “The Gladiator of the Geeks.” She’s a warrior. The last two years have been anything but ordinary for Riley Shepard. According to Shepard, it’s been rather challenging.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results